These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21108883)

  • 1. [Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients].
    Wang J; Sun Y; Liu Y; Yu Q; Zhang Y; Li K; Zhu Y; Zhou Q; Hou M; Guan Z; Li W; Zhuang W; Wang D; Liang H; Qin F; Lu H; Liu X; Sun H; Zhang Y; Wang J; Luo S; Yang R; Tu Y; Wang X; Song S; Zhou J; You L; Wang J; Yao C
    Zhongguo Fei Ai Za Zhi; 2005 Aug; 8(4):283-90. PubMed ID: 21108883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phase II clinical trial of homemade human rh-endostatin in the treatment of patients with stage IIIB-IV non-small cell lung cancer].
    Shi H; Xu L; Liu Z
    Zhongguo Fei Ai Za Zhi; 2004 Aug; 7(4):325-8. PubMed ID: 21241552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
    Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer.
    Yasuda H; Yamaya M; Nakayama K; Sasaki T; Ebihara S; Kanda A; Asada M; Inoue D; Suzuki T; Okazaki T; Takahashi H; Yoshida M; Kaneta T; Ishizawa K; Yamanda S; Tomita N; Yamasaki M; Kikuchi A; Kubo H; Sasaki H
    J Clin Oncol; 2006 Feb; 24(4):688-94. PubMed ID: 16446342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Randomized phase II trial on escalated doses of Rh-endostatin (YH-16) for advanced non-small cell lung cancer].
    Yang L; Wang JW; Sun Y; Zhu YZ; Liu XQ; Li WL; Di LJ; Li PW; Wang YL; Song SP; Yao C; You LF
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):138-41. PubMed ID: 16750022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A randomized study of docetaxel plus cisplatin versus paclitaxel plus cisplatin in previously untreated advanced non-small cell lung cancer.].
    Zhang S; Wang J; Wang Q; Yang X; Hu F; Li X; Gu Y; Wang H
    Zhongguo Fei Ai Za Zhi; 2008 Feb; 11(1):110-4. PubMed ID: 20727278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
    Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced MRI to predict response to vinorelbine-cisplatin alone or with rh-endostatin in patients with non-small cell lung cancer and bone metastases: a randomised, double-blind, placebo-controlled trial.
    Zhang R; Wang ZY; Li YH; Lu YH; Wang S; Yu WX; Zhao H
    Lancet; 2016 Oct; 388 Suppl 1():S95. PubMed ID: 27968915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A randomized clinical trial on taxol plus oxaliplatin versus taxol plus cisplatin as first-line treatment in advanced non-small cell lung cancer].
    Li M; Huang H; Tan J; Lin D
    Zhongguo Fei Ai Za Zhi; 2006 Oct; 9(5):452-4. PubMed ID: 21176470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A randomized clinical trial of gemcitabine plus cisplatin compared with gemcitabine plus vinorelbine in the treatment of non-small cell lung cancer].
    Zhang L; Li N; Xu F; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2005 Dec; 8(6):530-4. PubMed ID: 21208543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A randomized clinical study on efficacy of Aidi injection combined with chemotherapy in the treatment of advanced non-small cell lung cancer].
    Wang D; Chen Y; Ren J; Cai Y; Liu M; Zhan Q
    Zhongguo Fei Ai Za Zhi; 2004 Jun; 7(3):247-9. PubMed ID: 21232229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer.
    Mantovani G; Macciò A; Mulas C; Massa E; Madeddu C; Mura L; Contu P; Versace R
    Oncol Rep; 2002; 9(3):661-70. PubMed ID: 11956647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A randomized, prospective, multi-centre clinical trial of NP regimen (vinorelbine+cisplatin) plus Gensing Rg3 in the treatment of advanced non-small cell lung cancer patients].
    Sun Y; Lin H; Zhu Y; Feng J; Chen Z; Li G; Zhang X; Zhang Z; Tang J; Shi M; Hao X; Han H
    Zhongguo Fei Ai Za Zhi; 2006 Jun; 9(3):254-8. PubMed ID: 21172156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of vinorelbine in non-small-cell lung cancer. Provincial Lung Disease Site Group.
    Goss GD; Logan DM; Newman TE; Evans WK
    Cancer Prev Control; 1997; 1(1):28-38. PubMed ID: 9765724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies].
    Langer F; Helsberg K; Schütte WH; Leschinger MI
    Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China.
    Wu B; Chen H; Shen J; Ye M
    Clin Ther; 2011 Oct; 33(10):1446-55. PubMed ID: 21992806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
    J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic efficacy of chemotherapy combined with radiotherapy in 527 patients with stage III and IV non-small cell lung cancer].
    Wang A; Zhou H; Wen X; Yi Q; Zhou W; Wang W; Yao D; Xu J; Huang Z
    Zhongguo Fei Ai Za Zhi; 2007 Jun; 10(3):219-22. PubMed ID: 21118650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemetrexed: a multitargeted antifolate.
    Rollins KD; Lindley C
    Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.